An Open-label, Multicenter Study of the Safety of Twice

Project: Research project

Description

OTR3001 - An Open-label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain R
StatusFinished
Effective start/end date8/22/119/13/12

Funding

  • Pharmaceutical Research Associates

Fingerprint

Oxycodone
Opioid Analgesics
Tablets
Multicenter Studies
Safety
Pain